Efficacy and Cardiovascular Safety of Roxadustat in Dialysis-Dependent Chronic Kidney Disease: Pooled Analysis of Four Phase 3 Studies

被引：0

作者：

Jonathan Barratt

Wladyslaw Sulowicz

Michael Schömig

Ciro Esposito

Michael Reusch

James Young

Botond Csiky

机构：

[1] University of Leicester,Cardiovascular Sciences

[2] Collegium Medicum of the Jagiellonian University,Department of Nephrology

[3] Dialysis Center Heilbronn,Unit of Nephrology and Dialysis

[4] ICS Maugeri,2nd Department of Medicine and Nephrology

[5] University of Pavia,Diabetes Center

[6] Astellas Pharma Europe B.V.,undefined

[7] Astellas Pharma,undefined

[8] Inc.,undefined

[9] University of Pécs,undefined

[10] FMC Dialysis Centers,undefined

来源：

Advances in Therapy | 2021年 / 38卷

关键词：

Anemia; Cardiovascular; Chronic kidney disease; Darbepoetin alfa; Dialysis; Epoetin alfa; Erythropoiesis-stimulating agent; Roxadustat;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：5345 / 5360

页数：15

共 184 条